However, alternative weight loss options must be considered if you have a history of cardiac disease, hypertension, type 1 diabetes, or thyroid issues
*Licensing is subject to change
It is vital to have regular check-ups with your healthcare provider while on this drug
First, phase II clinical trials evaluating MOTS-c in type 2 diabetes and sarcopenia are in development, and their results will provide the first randomized controlled evidence in humans to define therapeutic doses with statistical rigor
Sweeteners: Rated 4/10 High sugar content (11g per serving)
Symptoms and Presentation Symptoms vary widely and can occur without anaemia or macrocytosis: Fatigue, weakness, shortness of breath